OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Genetic surveillance of SARS-CoV-2 Mpro reveals high sequence and structural conservation prior to the introduction of protease inhibitor Paxlovid
Jonathan T. Lee, Qingyi Yang, Alexey V. Gribenko, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
Jonathan T. Lee, Qingyi Yang, Alexey V. Gribenko, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
Showing 5 citing articles:
Discovery and Mechanism Study of SARS-CoV-2 3C-like Protease Inhibitors with a New Reactive Group
Pengxuan Ren, Hui Li, Tianqing Nie, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 17, pp. 12266-12283
Closed Access | Times Cited: 13
Pengxuan Ren, Hui Li, Tianqing Nie, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 17, pp. 12266-12283
Closed Access | Times Cited: 13
A ricin-based peptide BRIP from Hordeum vulgare inhibits Mpro of SARS-CoV-2
Prakriti Kashyap, Vijay Kumar Bhardwaj, Mahima Chauhan, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 20
Prakriti Kashyap, Vijay Kumar Bhardwaj, Mahima Chauhan, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 20
Detailed Insights into the Inhibitory Mechanism of New Ebselen Derivatives against Main Protease (Mpro) of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)
Pritiranjan Sahoo, Dipti Lenka, Monojit Batabyal, et al.
ACS Pharmacology & Translational Science (2022) Vol. 6, Iss. 1, pp. 171-180
Open Access | Times Cited: 20
Pritiranjan Sahoo, Dipti Lenka, Monojit Batabyal, et al.
ACS Pharmacology & Translational Science (2022) Vol. 6, Iss. 1, pp. 171-180
Open Access | Times Cited: 20
Recent changes in the mutational dynamics of the SARS-CoV-2 main-protease substantiate the danger of emerging resistance to antiviral drugs.
Christian Gruber, Lena Parigger, A. Krassnigg, et al.
Research Square (Research Square) (2022)
Open Access
Christian Gruber, Lena Parigger, A. Krassnigg, et al.
Research Square (Research Square) (2022)
Open Access
Changes in the mutational dynamics of the SARS-CoV-2 main-protease substantiate the danger of emerging resistance to antiviral drugs.
Lena Parigger, A. Krassnigg, Tobias Schopper, et al.
Research Square (Research Square) (2022)
Open Access
Lena Parigger, A. Krassnigg, Tobias Schopper, et al.
Research Square (Research Square) (2022)
Open Access
